AIG
TARA icon

American International Group’s Protara Therapeutics TARA Stock Holding History

American International Group’s Portfolio TARA Stock Details TARA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-2,254
Closed -$35 – 3265
2021
Q1 		$35 Buy
2,254
+5
+0.2% +$93 ﹤0.01% 3059
2020
Q4 		$54 Buy
2,249
+1,043
+86% +$22.5K ﹤0.01% 2941
2020
Q3 		$20K Sell
1,206
-27
-2% -$626 ﹤0.01% 3049
2020
Q2 		$36K Buy
+1,233
New +$38.2K ﹤0.01% 2973
2016
Q2 		– Sell
-113
Closed -$35K – 4309
2016
Q1 		$35K Hold
113
– – ﹤0.01% 4062
2015
Q4 		$70K Hold
113
– – ﹤0.01% 3713
2015
Q3 		$63K Hold
113
– – ﹤0.01% 3806
2015
Q2 		$80.7K Buy
+113
New +$69.9K ﹤0.01% 3821

Other funds holding TARA

OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

American International Group's TARA Position: Q2 2021 in Review

American International Group sold out of Protara Therapeutics (TARA) in Q2 2021, closing a stake of 2,254 shares — an estimated $35 sold.

American International Group first reported a position in TARA in Q2 2015 and held it in 8 quarters. The position peaked at $80.7K in Q2 2015. 41 funds tracked by Wall St. Rank hold TARA as of Q2 2021.

  • American International Group reported no remaining Protara Therapeutics position as of Q2 2021 after selling out during the quarter.
  • American International Group sold 2,254 Protara Therapeutics shares in Q2 2021, an estimated $35.
  • American International Group first reported a position in Protara Therapeutics in Q2 2015 and held it in 8 quarters.
  • American International Group's Protara Therapeutics position peaked at $80.7K in Q2 2015.
  • 41 funds tracked by Wall St. Rank held Protara Therapeutics as of Q2 2021.

Based on American International Group's 13F filing for Q2 2021, filed 13 Aug 2021.